REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Grant of Share Options to Chief Financial Officer

Mycelx TechnologiesAnnouncement

18/03/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240318:nRSR1413Ha&default-theme=true

RNS Number : 1413H  MyCelx Technologies Corporation  18 March 2024

18 March 2024

MYCELX Technologies Corporation

("MYCELX" or the "Company") (AIM: MYX)

 

 

Grant of Share Options to Chief Financial Officer

 

On 15 March 2024 Ms. Slayton, a PDMR of the Company, was awarded the following
options over the Company's common shares of US$0.025 each ("Common Shares")
under the MYCELX Omnibus Performance Incentive Plan ("Plan"):

 

 Name of PDMR      Number of share options granted  Exercise price  Total number of share options held following this notification  Total number of share options as % of current issued share capital

 Kimberly Slayton  50,000                           US$0.59         313,334                                                         1.36%

 

Ms. Slayton holds no Common Shares in the issued capital of the Company.

 

The share options granted to Kimberly Slayton on 15 March 2024 will vest as to
50% on 31 December 2024 and 50% on 31 December 2025. The exercise price was
based on the mid-market closing price of the Company's Common Shares at 15
March 2024, and the closing US/£ exchange rate at that date.

 

The above grant is included as part of wider grants of 300,000 options in
aggregate to employees across the Company on 13 March 2024 and 15 March 2024,
representing 1.31% of the current issued share capital. All of the options
must be exercised prior to the tenth anniversary of the date of grant, subject
to the restrictions on dealing under the Company's share dealing code.

 

Details of the transaction are reported in the PDMR notification below:

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated

 a)  Name                                                          Kimberly Slayton
 2   Reason for the notification

 a)  Position/status                                              Chief Financial Officer

 b)  Initial notification/Amendment                               Initial Notification

 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         MYCELX Technologies Corporation

 b)  LEI                                                          213800UJZINIK2VD1G48
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted

 a)  Description of the financial instrument, type of instrument  Grant of options over 50,000 common shares of US$0.025 each.

                                                                  ISIN: US62847T2024

 c)  Currency                                                     US$
 d)  Price(s) and volumes(s)                                      Price(s)                         Volume(s)

                                                                  US$0.59                          50,000
 e)  Aggregated information                                       As above

     -      Aggregated volume

     -      Price

 f)  Date of the transaction                                      15 March 2024
 g)  Place of the transaction                                     NA (grant of options)

 

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                  Tel: +1 888 306 6843

 Kim Slayton, CFO

 Canaccord Genuity Limited (Nomad and Sole Broker)

 Henry Fitzgerald-O'Connor                          Tel: +44 20 7523 8000

 Ana Ercegovic

 Celicourt Communications (Financial PR)

 Mark Antelme                                       Tel: +44 20 7770 6424

 Jimmy Lea

 Charlie Denley-Myerson

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHKZGMFKNLGDZM